Trademark: 77121298
Word
CELLCIPHR
Status
Registered
Status Code
800
Status Date
Wednesday, May 24, 2017
Serial Number
77121298
Registration Number
3343078
Registration Date
Tuesday, November 27, 2007
Mark Type
4000
Filing Date
Friday, March 2, 2007
Published for Opposition
Tuesday, September 11, 2007

Trademark Owner History
CYPROTEX US, LLC -
APREDICA LLC -
Cellumen, Inc. - Original Registrant

Classifications
1 [Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals namely, polypeptides for in vitro research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Chemical preparations for scientific purposes; Chemical test kits for cell assays for laboratory or research use; Cytological fixatives; Diagnostic preparations for scientific or research use; Enzymes for scientific and research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use]
42 [ Chemical, biochemical, biological and bacteriological research and analysis; Chemistry consultation; Consultancy pertaining to pharmacology; Design for others in the field of cellular profiling and biomedical assays; Development of new technology for others in the field of biomedical research; Diagnostic services in the field of biomedicine; Information on the subject of scientific research in the field of biochemistry and biotechnology; ] Laboratory research in the field of drug discovery and drug development; Measurement evaluations in the fields of cell biology and biomedicine; [ Medical and scientific research in the field of medical imaging; ] Medical and scientific research in the field of drug discovery and drug development; [ Medical and scientific research services in the field of cancer treatment and diagnosis; ] Medical research; [ Performance of chemical analyses; ] Pharmaceutical drug development services; [ Pharmaceutical product evaluation; ] Pharmaceutical research and development; Pharmaceutical research services; [ Research and development and consultation related thereto in the field of drug discovery and drug development; Research in the field of environmental protection; ] Scientific investigations for medical purposes; Scientific research [ ; Technology consultation and research in the field of biomedicine ]
In the statement, Column 1, lines 34 thru 39, "Chemical, biochemical, biological and bacteriological research and analysis; Chemistry consultation; Consultancy pertaining to pharmacology; Design for others in the field of cellular profiling and biomedical assays;" is deleted, and In the statement, Column 2, lines 1 thru 6, "Development of new technology for others in the field of biomedical research; Diagnostic services in the field of biomedicine; Information on the subject of scientific research in the field of biochemistry and biotechnology;" is deleted, and In the statement Column 2, lines 10 thru 12, "Medical and scientific research in the field of medical imaging;" should be deleted, and In the statement, Column 2, lines 14 thru 18, "Medical and scientific research services in the field of cancer treatment and diagnosis;" is deleted, and In the statement Column 2, line 18, "Performance of chemical analyses;" is deleted, and In the Statement, lines 18 and 19, "Pharmaceutical product evaluation;" should be deleted, and In the statement Column 2, lines 22 thru 26, "Research and development and consultation related thereto in the field of drug discovery and drug development; Research in the field of environmental protection;" is deleted, and In the statement Column 2, lines 28 thru 30, "; Technology consultation and research in the field of biomedicine" is deleted.
CELL CIPHER

Trademark Events
Nov 29, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 29, 2023
Teas Change Of Correspondence Received
Nov 29, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2022
Teas Change Of Correspondence Received
Oct 6, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 6, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2022
Teas Change Of Owner Address Received
Sep 30, 2020
Correction Under Section 7 ¿ Processed
Sep 30, 2020
Case Assigned To Post Registration Paralegal
Jul 17, 2020
Teas Section 7 Request Received
Jun 29, 2020
Teas Section 7 Request Received
May 26, 2020
Teas Section 7 Surrender Received
May 24, 2017
Notice Of Acceptance Of Sec. 8 - E-Mailed
May 24, 2017
Registered And Renewed (First Renewal - 10 Yrs)
May 24, 2017
Registered - Sec. 9 Granted/Check Record For Sec. 8
May 24, 2017
Registered - Partial Sec. 8 (10-Yr) Accepted
May 24, 2017
Case Assigned To Post Registration Paralegal
Mar 29, 2017
Teas Section 8 & 9 Received
Mar 29, 2017
Teas Change Of Correspondence Received
Nov 27, 2016
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jul 23, 2014
Automatic Update Of Assignment Of Ownership
Apr 1, 2013
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Apr 1, 2013
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Apr 1, 2013
Case Assigned To Post Registration Paralegal
Mar 14, 2013
Teas Section 8 & 15 Received
Mar 14, 2013
Teas Change Of Correspondence Received
Nov 7, 2012
Assignment Of Ownership Not Updated Automatically
Sep 14, 2011
Assignment Of Ownership Not Updated Automatically
Aug 31, 2011
Automatic Update Of Assignment Of Ownership
Feb 25, 2009
Assignment Of Ownership Not Updated Automatically
Nov 27, 2007
Registered-Principal Register
Nov 8, 2007
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 8, 2007
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 11, 2007
Published For Opposition
Aug 22, 2007
Notice Of Publication
Aug 8, 2007
Law Office Publication Review Completed
Aug 8, 2007
Assigned To Lie
Jun 23, 2007
Approved For Pub - Principal Register
Jun 14, 2007
Assigned To Examiner
Mar 8, 2007
Notice Of Pseudo Mark Mailed
Mar 7, 2007
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24